On August 4, 2016, Taiwan’s Executive Yuan (the executive branch of central government) passed a draft amendment to the Pharmaceutical Affairs Act (Amendment), which was proposed by the Ministry of Health and Welfare. This amendment was drafted in response to Taiwan’s negotiations on joining the Trade and Investment Framework Agreement (TIFA) and the Trans-Pacific Partnership (TPP) deal.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Phoebe Yeh, Tsai, Lee & Chen, patent, TIFA, Pharmaceutical Affairs Act, TPP, TFDA, pharmaceutical, drugs,
